A retrospective longitudinal study assessing the hemorrhage risk of direct oral anticoagulants in real-world Venous Thromboembolism patients in real world
Latest Information Update: 18 Aug 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions
- 18 Aug 2021 New trial record
- 01 Aug 2021 Results (N= 41830), of a comparative analysis of Apixaban versus Rivaroxaban published in the Thrombosis Research